CD19 and monoclonal gammopathy: Both MYD88 and CXCR4 mutations are detected in the bone marrow (BM), although there have been attempts to detect them in CD19+-selected cells in the peripheral blood (PB) of patients with IgM monoclonal gammopathies [20, 21].